PE62796A1 - Dispositivo de liberacion de droga intravaginal conteniendo un precursor de 17b-estradiol - Google Patents
Dispositivo de liberacion de droga intravaginal conteniendo un precursor de 17b-estradiolInfo
- Publication number
- PE62796A1 PE62796A1 PE1995287516A PE28751695A PE62796A1 PE 62796 A1 PE62796 A1 PE 62796A1 PE 1995287516 A PE1995287516 A PE 1995287516A PE 28751695 A PE28751695 A PE 28751695A PE 62796 A1 PE62796 A1 PE 62796A1
- Authority
- PE
- Peru
- Prior art keywords
- estradiol
- precursor
- drug release
- release device
- device containing
- Prior art date
Links
- 239000002243 precursor Substances 0.000 title abstract 5
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229960005309 estradiol Drugs 0.000 abstract 3
- -1 HYDROXYL GROUP Chemical group 0.000 abstract 2
- 230000000903 blocking effect Effects 0.000 abstract 1
- 239000012153 distilled water Substances 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- 229920001296 polysiloxane Polymers 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Reproductive Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Gynecology & Obstetrics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
Abstract
SE REFIERE AL DISPOSITIVO QUE COMPRENDE UN PRECURSOR DE 17�-ESTRADIOL TAL COMO 17�-ESTRADIOL-3-ACETATO, EN UNA MATRIZ DE POLIMEROS; ESTANDO ADAPTADO PARA LIBERAR EL PRECURSOR EN UN MODELO DE ORDEN CERO, DURANTE POR LO MENOS TRES SEMANAS; SIENDO EL PRECURSOR UNA MITAD DE 17�-ESTRADIOL, EN DONDE EL O CADA GRUPO HIDROXILO DE LA MITAD 17�-ESTRADIOL ES BLOQUEADA POR UN GRUPO BLOQUEANTE TAL COMO ACILO DE CADENA CORTA ALIFATICA O PROPIONILO, EL CUAL ES FACILMENTE ELIMINADO; TENIENDO EL PRECURSOR LIPOFILICIDAD O SOLUBILIDAD EN SILICONA LIQUIDA DE NO MENOS DE 0,1 mg/100ml; UN VALOR K ESTANDAR DE NO MENOS DE 0,1 �g/d/mm; HIDROFILICIDAD, SEGUN SE DETERMINA POR LA SOLUBILIDAD EN AGUA DESTILADA DE NO MENOS DE 1 �g/100ml
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IES940976 | 1994-12-19 | ||
| IES950247 | 1995-04-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE62796A1 true PE62796A1 (es) | 1996-12-28 |
Family
ID=26319777
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1995287516A PE62796A1 (es) | 1994-12-19 | 1995-12-19 | Dispositivo de liberacion de droga intravaginal conteniendo un precursor de 17b-estradiol |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US5855906A (es) |
| EP (1) | EP0799025B1 (es) |
| JP (1) | JPH10510825A (es) |
| CN (1) | CN1138526C (es) |
| AR (1) | AR002010A1 (es) |
| AT (1) | ATE178204T1 (es) |
| AU (1) | AU692659B2 (es) |
| CA (1) | CA2207622C (es) |
| DE (1) | DE69508791T2 (es) |
| DK (1) | DK0799025T3 (es) |
| ES (1) | ES2133841T3 (es) |
| FI (1) | FI119414B (es) |
| GR (1) | GR3030614T3 (es) |
| IL (1) | IL116433A (es) |
| NO (1) | NO316707B1 (es) |
| NZ (1) | NZ298490A (es) |
| PE (1) | PE62796A1 (es) |
| TR (1) | TR199501599A2 (es) |
| WO (1) | WO1996019196A1 (es) |
Families Citing this family (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6407082B1 (en) * | 1996-09-13 | 2002-06-18 | New Life Pharmaceuticals Inc. | Prevention of ovarian cancer by administration of a vitamin D compound |
| US6034074A (en) | 1996-09-13 | 2000-03-07 | New Life Pharmaceuticals Inc. | Prevention of ovarian cancer by administration of a Vitamin D compound |
| US6511970B1 (en) | 1996-09-13 | 2003-01-28 | New Life Pharmaceuticals Inc. | Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium |
| US6028064A (en) | 1996-09-13 | 2000-02-22 | New Life Pharmaceuticals Inc. | Prevention of ovarian cancer by administration of progestin products |
| US6765002B2 (en) | 2000-03-21 | 2004-07-20 | Gustavo Rodriguez | Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium |
| EP0981327B1 (en) | 1997-05-07 | 2002-11-06 | Galen (Chemicals) Limited | Intravaginal drug delivery devices for the administration of testosterone and testosterone precursors |
| US6039968A (en) * | 1997-06-24 | 2000-03-21 | Hoechst Marion Roussel | Intravaginal drug delivery device |
| US20050113351A1 (en) * | 2000-03-21 | 2005-05-26 | Rodriguez Gustavo C. | Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium |
| US20010044431A1 (en) * | 2000-03-21 | 2001-11-22 | Rodriguez Gustavo C. | Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium |
| US20040176336A1 (en) * | 2000-03-21 | 2004-09-09 | Rodriguez Gustavo C. | Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium |
| US6811549B2 (en) | 2001-02-16 | 2004-11-02 | William H. Fleming | Administration of therapeutic or diagnostic agents using interlabial pad |
| US6962908B2 (en) * | 2001-12-21 | 2005-11-08 | Warner Chilcott Company Inc. | Oral pharmaceutical products containing 17 β-estradiol-3-lower alkanoate, method of administering the same and process of preparation |
| WO2003080018A1 (en) * | 2002-03-27 | 2003-10-02 | Galen (Chemicals) Limited | Intravaginal matrix drug delivery devices |
| GB0222522D0 (en) | 2002-09-27 | 2002-11-06 | Controlled Therapeutics Sct | Water-swellable polymers |
| AU2004233997C1 (en) * | 2003-04-29 | 2014-01-30 | Massachusetts Institiute Of Technology | Methods and devices for the sustained release of multiple drugs |
| GB0417401D0 (en) | 2004-08-05 | 2004-09-08 | Controlled Therapeutics Sct | Stabilised prostaglandin composition |
| EP1853272A1 (en) * | 2005-02-03 | 2007-11-14 | Duramed Pharmaceuticals, Inc. | Compositions of unconjugated estrogens and methods for their use |
| EP1853221A2 (en) * | 2005-02-03 | 2007-11-14 | Duramed Pharmaceuticals, Inc. | Devices for delivering agents to a vaginal tract |
| DK1933810T3 (da) * | 2005-08-11 | 2013-01-28 | Childrens Medical Center | Intravesikal lægemiddelafgivelsesindretning og fremgangsmåde |
| US20070077269A1 (en) * | 2005-10-04 | 2007-04-05 | Woodward John R | Method of birth control and hormone regulation |
| CN103251449B (zh) * | 2005-10-13 | 2016-03-02 | 斯恩蒂斯有限公司 | 载药包装物 |
| GB0613333D0 (en) * | 2006-07-05 | 2006-08-16 | Controlled Therapeutics Sct | Hydrophilic polyurethane compositions |
| GB0613638D0 (en) * | 2006-07-08 | 2006-08-16 | Controlled Therapeutics Sct | Polyurethane elastomers |
| MX2009000053A (es) * | 2006-07-12 | 2009-02-23 | Controlled Therapeutics Sct | Polimero para el suministro de medicamentos con sal clorhidrato de clindamicina. |
| GB0620685D0 (en) * | 2006-10-18 | 2006-11-29 | Controlled Therapeutics Sct | Bioresorbable polymers |
| EP2170276B1 (en) * | 2007-06-26 | 2018-08-22 | Allergan Pharmaceuticals International Limited | Intravaginal drug delivery devices for the delivery of macromolecules and water-soluble drugs |
| KR101538748B1 (ko) * | 2007-12-11 | 2015-07-22 | 메사추세츠 인스티튜트 오브 테크놀로지 | 이식형 의약 투여 장치와 방광과 기타 신체 낭 또는 내강의 치료 방법 |
| EA201170297A1 (ru) * | 2008-08-09 | 2011-08-30 | Массачусетс Инститьют Оф Текнолоджи | Имплантируемое устройство для доставки лекарственных средств и способ лечения мужской мочеполовой системы и окружающих тканей |
| EP2437684B1 (en) | 2009-06-03 | 2022-06-15 | ForSight Vision5, Inc. | Anterior segment drug delivery |
| DK2445570T3 (da) | 2009-06-26 | 2013-02-25 | Taris Biomedical Inc | Implanterbare lægemiddelafgivelsesindretninger samt fremgangsmåder til deres fremstilling |
| US9017312B2 (en) | 2009-09-10 | 2015-04-28 | Taris Biomedical Llc | Implantable device for controlled drug delivery |
| US8580294B2 (en) | 2010-10-19 | 2013-11-12 | International Partnership For Microbicides | Platinum-catalyzed intravaginal rings |
| JP2014503554A (ja) | 2011-01-10 | 2014-02-13 | タリス バイオメディカル，インコーポレイテッド | 膀胱痛及び刺激性排尿の持続的治療の使用のためのリドカインレジメン |
| EP2670398B1 (en) | 2011-02-04 | 2017-06-07 | TARIS Biomedical LLC | Implantable device for controlled release of low solubility drug |
| EP2755615B1 (en) | 2011-09-14 | 2022-04-06 | Forsight Vision5, Inc. | Ocular insert apparatus |
| TWI590843B (zh) | 2011-12-28 | 2017-07-11 | 信迪思有限公司 | 膜及其製造方法 |
| DK2911623T3 (da) | 2012-10-26 | 2019-10-28 | Forsight Vision5 Inc | Oftalmisk system til langvarig frigivelse af lægemiddel til øjet |
| KR102557326B1 (ko) | 2013-03-15 | 2023-07-19 | 타리스 바이오메디컬 엘엘씨 | 약물-투과성 구성요소를 가지는 약물 전달 장치 |
| CN105555328B (zh) | 2013-06-21 | 2019-01-11 | 德普伊新特斯产品公司 | 膜及制造方法 |
| KR102385603B1 (ko) | 2013-08-19 | 2022-04-11 | 타리스 바이오메디컬 엘엘씨 | 다중 유닛 약물 전달 장치 및 방법 |
| CN104546668B (zh) * | 2013-10-23 | 2019-03-05 | 国家卫生计生委科学技术研究所 | 液体硅橡胶为载体的药物缓控释系统的制备及应用 |
| US10137031B2 (en) | 2013-11-14 | 2018-11-27 | International Partnership For Microbicides, Inc. | Combination therapy intravaginal rings |
| DK3125964T3 (da) * | 2014-04-01 | 2024-10-14 | Poly Med Inc | Antikonceptionsmiddel og relateret enhed |
| US20160296532A1 (en) | 2015-04-13 | 2016-10-13 | Forsight Vision5, Inc. | Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent |
| WO2016172704A1 (en) | 2015-04-23 | 2016-10-27 | Taris Biomedical Llc | Drug delivery devices with drug-permeable component and methods |
| CN114573654B (zh) * | 2020-12-01 | 2025-09-12 | 北京奇明达企业管理有限公司 | 17-O-乙酰-17-β雌二醇的自组装的三聚体、其制备、活性和应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3545439A (en) * | 1968-01-04 | 1970-12-08 | Upjohn Co | Medicated devices and methods |
| US4291014A (en) * | 1979-01-11 | 1981-09-22 | Key Pharmaceuticals, Inc. | Polymeric diffusion matrix containing estradiol diacetate |
| US4438139A (en) * | 1979-08-14 | 1984-03-20 | Key Pharmaceuticals, Inc. | Polymeric diffusion matrix containing estrogens |
| SE8602666D0 (sv) * | 1986-06-16 | 1986-06-16 | Leo Ab | Intravaginal devices |
-
1995
- 1995-12-18 IL IL11643395A patent/IL116433A/en not_active IP Right Cessation
- 1995-12-19 DE DE69508791T patent/DE69508791T2/de not_active Expired - Lifetime
- 1995-12-19 AT AT95942772T patent/ATE178204T1/de not_active IP Right Cessation
- 1995-12-19 JP JP8519650A patent/JPH10510825A/ja not_active Ceased
- 1995-12-19 PE PE1995287516A patent/PE62796A1/es not_active Application Discontinuation
- 1995-12-19 CA CA002207622A patent/CA2207622C/en not_active Expired - Lifetime
- 1995-12-19 ES ES95942772T patent/ES2133841T3/es not_active Expired - Lifetime
- 1995-12-19 NZ NZ298490A patent/NZ298490A/xx unknown
- 1995-12-19 EP EP95942772A patent/EP0799025B1/en not_active Expired - Lifetime
- 1995-12-19 AU AU43991/96A patent/AU692659B2/en not_active Ceased
- 1995-12-19 WO PCT/IE1995/000063 patent/WO1996019196A1/en not_active Ceased
- 1995-12-19 DK DK95942772T patent/DK0799025T3/da active
- 1995-12-19 TR TR95/01599A patent/TR199501599A2/xx unknown
- 1995-12-19 US US08/849,329 patent/US5855906A/en not_active Expired - Lifetime
- 1995-12-19 AR ARP950100619A patent/AR002010A1/es unknown
- 1995-12-19 CN CNB951968947A patent/CN1138526C/zh not_active Expired - Lifetime
-
1997
- 1997-06-17 NO NO19972798A patent/NO316707B1/no unknown
- 1997-06-17 FI FI972579A patent/FI119414B/fi not_active IP Right Cessation
-
1999
- 1999-06-29 GR GR990401699T patent/GR3030614T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0799025A1 (en) | 1997-10-08 |
| FI119414B (fi) | 2008-11-14 |
| DE69508791D1 (de) | 1999-05-06 |
| CA2207622A1 (en) | 1996-06-27 |
| FI972579A0 (fi) | 1997-06-17 |
| DK0799025T3 (da) | 1999-10-18 |
| DE69508791T2 (de) | 1999-12-02 |
| AR002010A1 (es) | 1998-01-07 |
| NO316707B1 (no) | 2004-04-13 |
| JPH10510825A (ja) | 1998-10-20 |
| AU692659B2 (en) | 1998-06-11 |
| ATE178204T1 (de) | 1999-04-15 |
| US5855906A (en) | 1999-01-05 |
| NO972798D0 (no) | 1997-06-17 |
| GR3030614T3 (en) | 1999-10-29 |
| AU4399196A (en) | 1996-07-10 |
| CN1170353A (zh) | 1998-01-14 |
| CN1138526C (zh) | 2004-02-18 |
| FI972579L (fi) | 1997-06-17 |
| ES2133841T3 (es) | 1999-09-16 |
| IL116433A (en) | 2002-02-10 |
| CA2207622C (en) | 2006-10-17 |
| NO972798L (no) | 1997-08-19 |
| NZ298490A (en) | 1999-11-29 |
| IL116433A0 (en) | 1996-03-31 |
| WO1996019196A1 (en) | 1996-06-27 |
| EP0799025B1 (en) | 1999-03-31 |
| TR199501599A2 (tr) | 1996-07-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE62796A1 (es) | Dispositivo de liberacion de droga intravaginal conteniendo un precursor de 17b-estradiol | |
| CR6656A (es) | Forma de dosificacion de farmacos accionada por un hidrogel | |
| AR027066A1 (es) | Forma de dosificacion de farmaco en capas impulsada por hidrogel | |
| PE20020307A1 (es) | Forma de dosificacion de farmaco activada por hidrogel | |
| BR0005915A (pt) | Comprimido matriz que possibilita a liberação prolongada de trimetazidina após a administração pela via oral | |
| ES2188787T3 (es) | Compuesto medicamentoso de micela copolimera y metodo para su preparacion. | |
| BR0014181A (pt) | Recipiente de policarbonato ramificado | |
| CO5570649A2 (es) | Producto antitranspirante en gel liquido de alta eficiencia | |
| BR0116438A (pt) | Composição catalìtica e métodos para a preparação da mesma e o uso da mesma em um processo de polimerização | |
| ES2112457T3 (es) | Procedimiento para la hidroformilacion de butadieno-1.3. | |
| MX9605869A (es) | Composiciones cosmeticas para el cabello. | |
| ES2087644T3 (es) | Procedimiento para producir resinas epoxi que contienen un esqueleto de bifenol. | |
| KR950005325A (ko) | 제약 조성물 | |
| ES2058977T3 (es) | Preparado absorbible por via percutanea a base de eperisona o tolperisona. | |
| MX170438B (es) | Sistemas detergentes de moldeo que tienen una fuente de halogeno estable en presencia de compuestos organicos facilmente oxidables | |
| BR0010521A (pt) | Composições farmacêuticas destinadas a administração por via oral de floroglucinol e sua preparação | |
| ES2140887T3 (es) | Procedimiento para cristalizar en agua (s)-n-n'-bis(2-hidroxi-1-(hidroximetil)etil)-5-((2-hidroxi-1-oxopropil)amino)-2,4,6-triyodo-1,3-bencenodicarboxamida. | |
| AR002981A1 (es) | Un envase que aloja una composicion farmaceutica que comprende una solucion acuosa de clorhidrato de procaterol, y una composicion farmaceutica quecomprende una solucion acuosa de clorhidrato de procaterol | |
| ES8407479A1 (es) | Un metodo para la preparacion de 5,6-dihidro-11h-dibenzo-(b,e)-azepin-6-onas. | |
| ES2092559T3 (es) | Formulacion farmaceutica que contiene penciclovir. | |
| LEE et al. | Anxiety, depression and impulsiveness according to military service duration in army-enlisted males | |
| CO4700301A1 (es) | Dispositivo para suministro intravaginal de drogas para ad- ministracion de precursores de 17b-estradiol | |
| MX9703839A (es) | Soluciones intravenosas de lubeluzol. | |
| HU et al. | Effects of clonidine on controlled hypotension induced by sodium nitroprusside | |
| Tapaneya-Olarn et al. | Acute glomerulonephritis in children: a prospective study. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application declared void or lapsed |